一个气发生器增强了肝细胞癌中免疫性跨动脉化学栓塞的作用
Lei Cao1, Li Ren2, Longlin Yin3
1Central Laboratory and Ultrasound Medicine and Computational Cardiology Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, PR China; Department of Radiology, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu 610072, Sichuan, PR China; Department of Interventional Radiology, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou, PR China.
这项研究引入了一种使用生成器治疗肝细胞癌 (HCC) 的新型跨动脉化学栓塞 (TACE) 方法. 这种方法重塑瘤微环境,增强化疗免疫疗法,改善治疗结果.
科学领域:
- 在瘤学瘤学.
- 生物医学工程 生物医学工程
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 常规的跨动脉化学血栓化 (TACE) 由于瘤微环境 (TME) 缺氧和酸化而面临限制.
- 这些因素往往会影响治疗的有效性,导致瘤复发.
研究的目的:
- 开发一种创新的TACE系统,重塑TME以增强对HCC的化疗免疫治疗反应.
- 调查局部释放和epirubicin (EPI) 输送的协同效应.
主要方法:
- 将气发生器 (化,CaH2) 纳入EPI化油栓塞系统,用于局部释放气.
- 通过TACE同时输送纳米-CaH2颗粒,释放气 (H2) 和离子 (Ca2+).
主要成果:
- 释放的能破坏了癌细胞的线粒体功能,减少了氧气消耗,缓解了瘤缺氧,抵消了化学阻力.
- 埃皮鲁比 (EPI) 诱导免疫细胞死亡 (ICD),激活抗瘤免疫反应.
- 氧化离子中和了TME酸化,减少了免疫抑制,并放大了化疗-免疫治疗协同作用.
结论:
- 新的CaH2集成TACE策略有效地重塑TME,增强HCC的化疗免疫疗法.
- 这种方法显示出改善TACE疗效和癌症治疗中的临床翻译的巨大潜力.
更多相关视频
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
相关概念视频
Hydrogen Bonds
Hydrogen Bonds Control the World!
Because hydrogen has very weak electronegativity when it binds with a strongly electronegative atom, such as oxygen or nitrogen, electrons in the bond are unequally shared....
Hydrogen Bonds
Self-Evaluation: Self-Enhancement and Self-Verification
Reduction of Alkenes: Catalytic Hydrogenation
Metals like palladium, platinum, and nickel are commonly used in their solid forms — fine powder on an inert surface. As these catalysts remain insoluble in the reaction mixture, they are referred to as heterogeneous catalysts.
The hydrogenation process takes place on the...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
